Sai Parenteral's
02 Apr '26MAINBOARD
Min. Investment
₹14,136
Issue size
₹408.79 Cr
GMP
Locked
Overall subscription: 1.05x
Check allotment status
Expert verdict
IPO dates
24 Mar
Opening
27 Mar
Closing
30 Mar
Allotment
02 Apr
Listing
*Refunds will be initiated on 01 Apr '26
IPO quota
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 38 | ₹14,896 |
| HNI (Min) | 14 | 532 | ₹2,08,544 |
Subscription (as on 01 July 2026, 06:30 PM)
Overall1.05x
Qualified institutional buyers
Non-Institutional Buyers
Retail Investors
Employee
About company
Founded: 2001|MD: Mr Anil Kumar Karusala
- Sai Parenteral’s Limited is a pharmaceutical formulations company engaged in the research, development, and manufacturing of pharmaceutical products. The company operates in two main segments: branded generic formulations and contract development and manufacturing organisation (CDMO) services for domestic and international markets.
- Its product portfolio covers multiple therapeutic areas, including cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins and supplements, analgesics, and dermatology. The company manufactures products in several dosage forms such as injectables, tablets, capsules, liquid orals, and ointments.
- Sai Parenterals supplies its branded generic formulations to customers, including government agencies, pharmaceutical companies, hospitals, and distributors in India, and also exports products to markets such as Australia, New Zealand, Southeast Asia, the Middle East, and Africa.
- The company operates five manufacturing facilities in India, four of which are located in Hyderabad, Telangana, while another facility owned by its subsidiary Revat Laboratories is located in Ongole, Andhra Pradesh. These facilities manufacture pharmaceutical formulations in compliance with applicable regulatory standards.
Issue Details & Objective
Lot size
38 Shares
Price band
₹372 to 392
Face value
₹5 per share
Financials
IPO reservation
Anchor investor - 30.00%
QIB - 20.00%
HNI - 15.00%
Retail - 35.00%
Download DRHP (IPO Doc)FAQs
Our SEBI-registered investment advisors give out verdicts for each IPO. You can refer to their expert verdict at the top of this page. Please note that these verdicts are for informational purposes only and should not be construed as investment advice. Markets are subject to risk, and investors should exercise their own discretion and diligence.
The issue size of Sai Parenteral's IPO is ₹408.79 Cr
The Sai Parenteral's IPO will be open for applications from 24 Mar '26 to 27 Mar '26
The lot size of Sai Parenteral's IPO is 38 Shares and its minimum investment amount is ₹14,136.
